Variant report
Variant | nsv876685 |
---|---|
Chromosome Location | chr3:34615754-34662157 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs13074645 | chr3:34615754-34615755 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs554403513 | chr3:34615766-34615767 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369194344 | chr3:34615792-34615793 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537739664 | chr3:34615877-34615878 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs17031936 | chr3:34615898-34615899 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs541856690 | chr3:34615918-34615919 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs34410622 | chr3:34616011-34616012 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs111356353 | chr3:34616013-34616014 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs35259650 | chr3:34616016-34616017 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs35139729 | chr3:34616017-34616018 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs560119403 | chr3:34616063-34616064 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs572169250 | chr3:34616224-34616225 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs376407257 | chr3:34616241-34616242 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs115286118 | chr3:34616279-34616280 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs35587511 | chr3:34616374-34616375 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185609739 | chr3:34616401-34616402 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs373823804 | chr3:34616402-34616403 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs190749627 | chr3:34616403-34616404 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562233056 | chr3:34616446-34616447 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs529637295 | chr3:34616499-34616500 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs34441662 | chr3:34616502-34616503 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs539651495 | chr3:34616533-34616534 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547370323 | chr3:34616546-34616547 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs183042424 | chr3:34616548-34616549 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs538462898 | chr3:34616593-34616594 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs17031937 | chr3:34616636-34616637 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs146413623 | chr3:34616648-34616649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs78065445 | chr3:34616656-34616657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs140825540 | chr3:34616667-34616668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555585275 | chr3:34616679-34616680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs573809452 | chr3:34616704-34616705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs534928798 | chr3:34616713-34616714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs17031938 | chr3:34616728-34616729 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs139021912 | chr3:34616737-34616738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs545819764 | chr3:34616739-34616740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564223536 | chr3:34616831-34616832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs116109499 | chr3:34616834-34616835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543649534 | chr3:34616857-34616858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs115184269 | chr3:34616895-34616896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs116317980 | chr3:34616896-34616897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs188584965 | chr3:34616901-34616902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs193261802 | chr3:34616958-34616959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs532941901 | chr3:34616987-34616988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs143760862 | chr3:34616990-34616991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs569649050 | chr3:34617005-34617006 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs78061357 | chr3:34617026-34617027 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs148147071 | chr3:34617027-34617028 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs112234500 | chr3:34617065-34617066 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540972612 | chr3:34617075-34617076 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182910064 | chr3:34617107-34617108 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Wilms tumour | 17204608 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:34615400-34616600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr3:34615600-34617400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr3:34617000-34617600 | Enhancers | Fetal Brain Female | brain |
4 | chr3:34624600-34625400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
5 | chr3:34627800-34628200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr3:34628200-34628400 | ZNF genes & repeats | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr3:34633400-34635600 | Weak transcription | Thymus | Thymus |
8 | chr3:34637400-34638600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr3:34637600-34638800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr3:34645000-34645600 | ZNF genes & repeats | Aorta | Aorta |
11 | chr3:34652600-34653000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |